VolitionRX Ltd. (VNRX)
0.2406
+0.01
(+3.71%)
USD |
NYAM |
Oct 06, 16:00
0.2406
0.00 (0.00%)
After-Hours: 19:41
VolitionRX Cash from Operations (Quarterly) : -4.993M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.993M |
| March 31, 2026 | -5.280M |
| December 31, 2025 | -5.092M |
| September 30, 2025 | -3.476M |
| June 30, 2025 | -6.419M |
| March 31, 2025 | -4.298M |
| December 31, 2024 | -5.129M |
| September 30, 2024 | -5.505M |
| June 30, 2024 | -6.496M |
| March 31, 2024 | -8.342M |
| December 31, 2023 | 6.373M |
| September 30, 2023 | -8.325M |
| June 30, 2023 | -7.227M |
| March 31, 2023 | -8.745M |
| December 31, 2022 | -5.010M |
| September 30, 2022 | -6.287M |
| June 30, 2022 | -6.229M |
| March 31, 2022 | 2.990M |
| December 31, 2021 | -4.366M |
| September 30, 2021 | -4.426M |
| June 30, 2021 | -5.416M |
| March 31, 2021 | -6.165M |
| December 31, 2020 | -2.855M |
| September 30, 2020 | -4.802M |
| June 30, 2020 | -4.467M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.799M |
| December 31, 2019 | -2.725M |
| September 30, 2019 | -3.767M |
| June 30, 2019 | -2.793M |
| March 31, 2019 | -3.651M |
| December 31, 2018 | -3.743M |
| September 30, 2018 | -4.415M |
| June 30, 2018 | -2.924M |
| March 31, 2018 | -3.506M |
| December 31, 2017 | -3.871M |
| September 30, 2017 | -2.708M |
| June 30, 2017 | -2.822M |
| March 31, 2017 | -2.670M |
| December 31, 2016 | -2.069M |
| September 30, 2016 | -2.093M |
| June 30, 2016 | -2.431M |
| March 31, 2016 | -2.161M |
| December 31, 2015 | -1.984M |
| September 30, 2015 | -2.406M |
| June 30, 2015 | -1.921M |
| March 31, 2015 | -2.206M |
| December 31, 2014 | -0.9219M |
| September 30, 2014 | -0.8764M |
| June 30, 2014 | -1.327M |
| March 31, 2014 | -0.9776M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 347.16M |
| Neogen Corp. | 30.20M |
| QuidelOrtho Corp. | -110.60M |
| Aspira Women's Health, Inc. | -2.01M |
| Lucid Diagnostics, Inc. | -11.30M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0016M |
| Cash from Financing (Quarterly) | 4.778M |
| Free Cash Flow | -18.86M |
| Free Cash Flow Per Share (Quarterly) | -0.5456 |
| Free Cash Flow to Equity (Quarterly) | -4.702M |
| Free Cash Flow to Firm (Quarterly) | -3.849M |
| Free Cash Flow Yield | -1.14K% |